SCHEMBL6003156

SCHEMBL6003156

[O]Cc1ccc(Oc2ccccc2)c(Oc2ccccc2)c1Oc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CAMK2A Q9UQM7 1/20 0.41
HRH1 P35367 1/20 0.41
SLC6A4 P31645 2/20 0.40
RIPK1 Q13546 1/20 0.40
SLC6A2 P23975 1/20 0.40
LTA4H P09960 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
TTR P02766 2/20 0.39
HTR2A P28223 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CTNNB1 P35222 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
MAPT P10636 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10659522 0.80 HRH1 (0.40) CAMK2AHRH1SLC6A4RIPK1SLC6A2
SCHEMBL19205830 0.80 LTA4H (0.55) HRH1SLC6A4RIPK1SLC6A2LTA4H
SCHEMBL2046663 0.76 HRH1 (0.60) HRH1SLC6A4RIPK1SLC6A2LTA4H
SCHEMBL27941087 0.76 RHEB (0.42) CAMK2AHRH1SLC6A4RIPK1SLC6A2
SCHEMBL10658806 0.75 SLC6A4 (0.36) CAMK2AHRH1SLC6A4RIPK1SLC6A2
SCHEMBL8942339 0.75 TSHR (0.44) LTA4HTSHRKMT2ALMNAGAA
SCHEMBL2093110 0.74 CAMK2A (0.49) CAMK2AHRH1SLC6A4RIPK1SLC6A2
SCHEMBL23174980 0.73 THRB (0.48) CAMK2AKMT2AGAATTRSMN1; SMN2
SCHEMBL982234 0.71 TTR (0.50) LTA4HTSHRKMT2ATTRCTNNB1
SCHEMBL5034123 0.71 LTA4H (0.44) HRH1LTA4HTSHRKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed